Udo Henseler, Director at RTI Biologics, Inc. (RTIX), bought 4,500 shares at $1.98 ($9K) on 2008-11-25, disclosed to the SEC on 2008-12-03.
Open-market purchase of $9k RTIX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.83 | 1,000 | $2K | 20.2% |
| 2 | $1.98 | 500 | $990 | 11.0% |
| 3 | $1.91 | 1,000 | $2K | 21.1% |
| 4 | $2.15 | 1,800 | $4K | 42.8% |
| 5 | $2.19 | 200 | $438 | 4.8% |
| Total | $2.01 avg | 4,500 |
| $9K |
| 100% |
| Filing → |
| RTIX | BUY | 2008-11-24 | $18K | — | Filing → |
| RTIX | SELL | 2008-08-20 | $40K | — | Filing → |
| RTIX | SELL | 2008-08-06 | $91K | — | Filing → |